1431325-96-0

Basic information

• Product Name: N-[2-((4-isopropylbenzoyl)oxy)propyl]-N,N-dimethylcyclohexanaminium iodide
• Synonyms: N-[2-((4-isopropylbenzoyl)oxy)propyl]-N,N-dimethylcyclohexanaminium iodide
• CAS NO: 1431325-96-0
• Molecular Weight: 459.411
• Mol File: 1431325-96-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[2-((4-isopropylbenzoyl)oxy)propyl]-N,N-dimethylcyclohexanaminium iodide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-((4-isopropylbenzoyl)oxy)propyl]-N,N-dimethylcyclohexanaminium iodide(1431325-96-0)
• EPA Substance Registry System: N-[2-((4-isopropylbenzoyl)oxy)propyl]-N,N-dimethylcyclohexanaminium iodide(1431325-96-0)

Safety Data

• Hazardous Substances Data: 1431325-96-0(Hazardous Substances Data)

Upstream product

• 108-94-1 cyclohexanone 
• 1431326-54-3 C₁₅H₂₀O₄ 
• 78345-60-5 1-(cyclohexyl(methyl)amino)propan-2-ol 
• 1431326-51-0 1-(cyclohexyl(methyl)amino)propan-2-yl-4-isopropylbenzoate 
• 74-88-4 methyl iodide 
• 536-66-3 p-isopropylbenzoic acid 
• 103-00-4 1-(cyclohexylamino)-2-propanol 

Relevant articles and documents

Cyclohexylamines

The present application provides novel compounds and methods for preparing and using these compounds. These compounds are useful in treating pain, itch, overactive bladder and/or interstitial cystitis in patients by administering one or more of the compounds to a patient. The methods include administering a compound of formula (I) and a TRPV1 receptor activator. In one embodiment, the TRPV1 receptor activator is lidocaine.